GlassScriptPhysician profile
Nicholas W Anast
NPI 1477877173
$28,434.44
in general payments reported to CMS, 2019-2025
11 companies · $1,417 in 2025
The $1,417 reported for 2025 was more than what 95% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $142 · 2021: $495 · 2022: $21K · 2023: $4,265 · 2024: $773 · 2025: $1,417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,235 · Food and Beverage: $2,220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,235.00 |
| Food and Beverage | $2,220.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $26,321.36 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $933.79 | 2021-2025 | Watchman Flx, Watchman Access System, Farapulse |
| Biosense Webster, INC. | $628.39 | 2024-2025 | Carto 3, Qdot Micro Catheter |
| Medtronic, INC. | $201.24 | 2025 | Onyx Frontier, Cobalt Dr Mri Surescan, Micra |
| Abbott Laboratories | $137.20 | 2021-2024 | Mitraclip |
| Silk Road Medical, INC. | $119.92 | 2021 | |
| Abiomed | $22.72 | 2021 | |
| Angiodynamics, INC. | $21.91 | 2023 | Bioflo |
| Merck Sharp & Dohme LLC | $17.04 | 2023 | Bridion |
| Getinge USA Sales, LLC | $16.88 | 2023 | Cardiosave Hybrid, Type B Plug |
| Medtronic Vascular, INC. | $13.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Anast listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.